A recent scientific workshop sponsored by the US National Kidney Foundation, in collaboration with the US Food and Drug Administration and European Medicines Agency (NKF-FDA-EMA) Workshop evaluated candidate surrogate endpoints for clinical trials of drugs to slow kidney disease progression, particularly among participants with early stages of chronic kidney disease (CKD).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |